Changes in BMI after treatment of testicular cancer are due to age and hormonal function and not chemotherapy [2] (multiple letters)

British Journal of Cancer

Volumn 89, Issue 6, 2003, Pages 1143-1145

  Huddart, R A ^a   Norman, A ^a   Nord, C ^b   Fossa S D ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TESTOSTERONE;

BODY MASS; HORMONAL REGULATION; HUMAN; LETTER; MALE; MULTIMODALITY CANCER THERAPY; ORCHIECTOMY; PRIORITY JOURNAL; TESTIS CANCER; TESTOSTERONE BLOOD LEVEL;

ADULT; AGE DISTRIBUTION; BODY MASS INDEX; BODY WEIGHT; DISEASE-FREE SURVIVAL; HORMONES; HUMANS; MALE; MIDDLE AGED; TESTICULAR NEOPLASMS;

EID: 0141956254     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601178     Document Type: Letter

References (0)